本页面由Tiger Trade Technology Pte. Ltd.提供服务

乌龙制药

38.28
+1.453.94%
盘后:38.280.00000.00%19:30 EDT
成交量:53.10万
成交额:2,004.26万
市值:18.64亿
市盈率:-19.43
高:38.32
开:36.97
低:36.20
收:36.83
52周最高:50.81
52周最低:15.86
股本:4,868.23万
流通股本:4,335.38万
量比:0.31
换手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-1.9700
每股收益(LYR):-3.1901
净资产收益率:-1481.26%
总资产收益率:-18.06%
市净率:-14.08
市盈率(LYR):-12.00

数据加载中...

2026/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

重要事件披露

Form 8-K - Current report
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/06/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]